Advertisement

Infective Endocarditis

  • Gilbert Habib
  • Maria Abellas-Sequeiros
Chapter

Abstract

Infective endocarditis (IE) is a changing disease, with new high-risk patients, new diagnostic procedures, new microorganisms involved and new therapeutic methods. The present chapter will update our knowledge in the field of infective endocarditis including new diagnostic strategies, the need to create an endocarditis team in reference centres, current guidelines concerning the management of these patients and the best way to prevent this deadly disease.

Keywords

Endocarditis Valve disease Imaging Echocardiography Nuclear imaging Surgery 

References

  1. 1.
    Habib G. Management of infective endocarditis. Heart. 2006;92:124–30.PubMedPubMedCentralCrossRefGoogle Scholar
  2. 2.
    Hasbun R, Vikram HR, Barakat LA, Buenconsejo J, Quagliarello VJ. Complicated left-sided native valve endocarditis in adults: risk classification for mortality. JAMA. 2003;289(15):1933–40.PubMedCrossRefGoogle Scholar
  3. 3.
    Duval X, Delahaye F, Alla F, et al. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol. 2012;59(22):1968–76.PubMedCrossRefGoogle Scholar
  4. 4.
    Hubert S, Thuny F, Resseguier N, et al. Prediction of symptomatic embolism in infective endocarditis: construction and validation of a risk calculator in a multicenter cohort. J Am Coll Cardiol. 2013;62:1384–92.PubMedCrossRefGoogle Scholar
  5. 5.
    Habib G. Embolic risk in subacute bacterial endocarditis. Role of transesophageal echocardiography. Curr Cardiol Rep. 2003;5:129–36.PubMedCrossRefPubMedCentralGoogle Scholar
  6. 6.
    Pant S, Patel NJ, Deshmukh A, et al. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol. 2015;65(19):2070–6.  https://doi.org/10.1016/j.jacc.2015.03.518.CrossRefPubMedGoogle Scholar
  7. 7.
    Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169(5):463–73.PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Athan E, Chu VH, Tattevin P, et al. Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. JAMA. 2012;307(16):1727–35.PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    Zlug D, Lacroix D, Savoye C, et al. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation. 1997;95(8):2098–107.CrossRefGoogle Scholar
  10. 10.
    Fernandez-Hidalgo N, Almirante B, Tornos P, Pigrau C, Sambola A, Igual A, Pahissa A. Contemporary epidemiology and prognosis of health care-associated infective endocarditis. Clin Infect Dis. 2008;47:1287–97.PubMedCrossRefPubMedCentralGoogle Scholar
  11. 11.
    Wang A, Gaca JG, Chu VH. Management considerations in infective endocarditis: a review. JAMA. 2018;320(1):72–83.PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Otsugu M, et al. Contribution of streptococcus mutans strains with collagen-binding proteins in the presence of serum to the pathogenesis of infective endocarditis. Infect Immun. 2017;85(12).Google Scholar
  13. 13.
    Madani A, Garakani K, Mofrad MRK. Molecular mechanics of Staphylococcus aureus adhesin, CNA, and the inhibition of bacterial adhesion by stretching collagen. PLoS One. 2017;12(6):e0179601.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Hienz SA, Schennings T, Heimdahl A, Flock J-I. Collagen binding of Staphylococcus aureus is a virulence factor in experimental endocarditis. J Infect Dis. 1996;174:83–8. pmid: 8656018.PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    DeLorenze GN, Nelson CL, Scott WK, Allen AS, Ray GT, Tsai A-L, et al. Polymorphisms in HLA Class II genes are associated with susceptibility to Staphylococcus aureus infection in a white population. J Infect Dis. 2016;213:816–23.PubMedCrossRefPubMedCentralGoogle Scholar
  16. 16.
    Klug D, Lacroix D, Savoye C, et al. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation. 1997;95:2098–107.PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    Thuny F, Di Salvo G, Belliard O, Avierinos JF, Pergola V, Rosenberg V, Casalta JP, Gouvernet J, Derumeaux G, Iarussi D, Ambrosi P, Calabro R, Riberi A, Collart F, Metras D, Lepidi H, Raoult D, Harle JR, Weiller PJ, Cohen A, Habib G. Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study. Circulation. 2005;112:69–75.PubMedCrossRefGoogle Scholar
  18. 18.
    Gursul NC, Vardar I, Demirdal T, Gursul E, Ural S, Yesil M. Clinical and microbiological findings of infective endocarditis. J Infect Dev Ctries. 2016;10(5):478–87.PubMedCrossRefGoogle Scholar
  19. 19.
    Yu CW, Juan LI, Hsu SC, Chen CK, Wu CW, Lee CC, Wu JY. Role of procalcitonin in the diagnosis of infective endocarditis: a meta-analysis. Am J Emerg Med. 2013;31:935–41.PubMedCrossRefGoogle Scholar
  20. 20.
    Olmos C, et al. Risk score for cardiac surgery in active left-sided infective endocarditis. Heart. 2017;103(18):1435–42.PubMedCrossRefGoogle Scholar
  21. 21.
    Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC guidelines for the management of infective endocarditis: the task force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC) endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36:3075–128.PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med. 1994;96:200–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Habib G, Badano L, Tribouilloy C, Vilacosta I, Zamorano JL, On behalf of the European Association of Echocardiography. Recommendations for the practice of echocardiography in infective endocarditis. Eur J Echocardiogr. 2010;11:202–19.PubMedCrossRefGoogle Scholar
  24. 24.
    Habib G, Derumeaux G, Avierinos JF, et al. Value and limitations of the Duke criteria for the diagnosis of infective endocarditis. J Am Coll Cardiol. 1999;33:2023–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Bai AD, et al. Diagnostic accuracy of transthoracic echocardiography for infective endocarditis findings using transesophageal echocardiography as the reference standard: a meta-analysis. J Am Soc Echocardiogr. 2017;30(7):639–646.e8.PubMedCrossRefGoogle Scholar
  26. 26.
    Evangelista A, Gonzalez-Alujas MT. Echocardiography in infective endocarditis. Heart. 2004;90:614–7.PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Lambl V. Papillare exkreszenzen an der semilunar-klappe der aorta. Wien Med Wochenschr. 1856;6:244–7.Google Scholar
  28. 28.
    San Roman JA, Lopez J, Vilacosta I, et al. Prognostic stratification of patients with left-sided endocarditis determined at admission. Am J Med. 2007;120:369 e361–7.CrossRefGoogle Scholar
  29. 29.
    Lauridsen TK, et al. Echocardiographic findings predict in-hospital and 1-year mortality in left-sided native valve Staphylococcus aureus endocarditis: analysis from the international collaboration on endocarditis-prospective Echo cohort study. Circ Cardiovasc Imaging. 2015;8(7):e003397.PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Di Salvo G, Habib G, Pergola V, et al. Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol. 2001;37:1069–76.PubMedCrossRefGoogle Scholar
  31. 31.
    Kang DH, Kim YJ, Kim SH, et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med. 2012;366:2466–73.PubMedCrossRefGoogle Scholar
  32. 32.
    Tischler MD, Vaitkus PT. The ability of vegetation size on echocardiography to predict clinical complications: a meta-analysis. J Am Soc Echocardiogr. 1997;10:562–8.PubMedCrossRefGoogle Scholar
  33. 33.
    Mohananey D, et al. Association of vegetation size with embolic risk in patients with infective endocarditis: a systematic review and meta-analysis. JAMA Intern Med. 2018;178(4):502–10.PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Narducci ML, Pelargiono G, Russo E, et al. Usefulness of intracardiac echocardiography for the diagnosis of cardiovascular implantable electronic device-related endocarditis. J Am Coll Cardiol. 2013;61:1398–405.PubMedCrossRefGoogle Scholar
  35. 35.
    Pfister R, et al. Three-dimensional compared to two-dimensional transesophageal echocardiography for diagnosis of infective endocarditis. Infection. 2016;44(6):725–31.PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Sungur A, et al. The advantages of live/real time three-dimensional transesophageal echocardiography in the assessment of tricuspid valve infective endocarditis. Echocardiography. 2014;31(10):1293–309.PubMedCrossRefPubMedCentralGoogle Scholar
  37. 37.
    Karwhar RB, et al. Ruptured anterior mitral leaflet aneurysm in aortic valve infective endocarditis—evaluation by three-dimensional echocardiography. Echocardiography. 2014;31(3):E72–6.CrossRefGoogle Scholar
  38. 38.
    Feuchtner GM, Stolzmann P, Dichtl W, et al. Multislice computed tomography in infective endocarditis: comparison with transesophageal echocardiography and intraoperative findings. J Am Coll Cardiol. 2009;53(5):436–44.PubMedCrossRefPubMedCentralGoogle Scholar
  39. 39.
    Fagman E, Perrotta S, Bech-Hanssen O, et al. ECG-gated computed tomography: a new role for patients with suspected aortic prosthetic valve endocarditis. Eur Radiol. 2012;22(11):2407–14.PubMedCrossRefPubMedCentralGoogle Scholar
  40. 40.
    Koo HJ, et al. Demonstration of infective endocarditis by cardiac CT and transoesophageal echocardiography: comparison with intra-operative findings. Eur Heart J Cardiovasc Imaging. 2018;19(2):199–207.PubMedCrossRefGoogle Scholar
  41. 41.
    Kim IC, et al. Comparison of cardiac computed tomography with transesophageal echocardiography for identifying vegetation and intracardiac complications in patients with infective endocarditis in the era of 3-dimensional images. Circ Cardiovasc Imaging. 2018;11(3):e006986.PubMedCrossRefPubMedCentralGoogle Scholar
  42. 42.
    Hekimian G, Kim M, Passefort S, Duval X, Wolff M, Leport C, Leplat C, Steg G, Iung B, Vahanian A, Messika-Zeitoun D. Preoperative use and safety of coronary angiography for acute aortic valve infective endocarditis. Heart. 2010;96:696–700.PubMedCrossRefGoogle Scholar
  43. 43.
    Duval X, Iung B, Klein I, et al. Effect of early cerebral magnetic resonance imaging on clinical decisions in infective endocarditis: a prospective study. Ann Intern Med. 2010;152:497–504.PubMedCrossRefGoogle Scholar
  44. 44.
    Snygg-Martin U, Gustafsson L, Rosengren L, et al. Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage markers. Clin Infect Dis. 2008;47:23–30.PubMedCrossRefPubMedCentralGoogle Scholar
  45. 45.
    Iung B, Klein I, Mourvillier B, Olivot JM, Detaint D, Longuet P, Ruimy R, Fourchy D, Laurichesse JJ, Laissy JP, Escoubet B, Duval X. Respective effects of early cerebral and abdominal magnetic resonance imaging on clinical decisions in infective endocarditis. Eur Heart J Cardiovasc Imaging. 2012;13:703–10.PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    Thuny F, Gaubert JY, Jacquier A, et al. Imaging investigations in infective endocarditis: current approach and perspectives. Arch Cardiovasc Dis. 2013;106:52–62.PubMedCrossRefPubMedCentralGoogle Scholar
  47. 47.
    Saby L, Laas O, Habib G, et al. Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion. J Am Coll Cardiol. 2013;61:2374–82.PubMedCrossRefPubMedCentralGoogle Scholar
  48. 48.
    Tattevin P, et al. Update on blood culture-negative endocarditis. Med Mal Infect. 2015;45(1–2):1–8.PubMedCrossRefPubMedCentralGoogle Scholar
  49. 49.
    Botelho-Nevers E, Thuny F, Casalta JP, et al. Dramatic reduction in infective endocarditis-related mortality with a management-based approach. Arch Intern Med. 2009;169:1290–8.PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2014;63:2438–88.PubMedCrossRefPubMedCentralGoogle Scholar
  51. 51.
    Tornos P, Iung B, Permanyer-Miralda G, Baron G, Delahaye F, Gohlke-Barwolf C, Butchart EG, Ravaud P, Vahanian A. Infective endocarditis in Europe: lessons from the Euro Heart Survey. Heart. 2005;91:571–5.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Vikram HR, Buenconsejo J, Hasbun R, Quagliarello VJ. Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis. A propensity analysis. JAMA. 2003;290:3207–14.PubMedCrossRefPubMedCentralGoogle Scholar
  53. 53.
    Bashore TM, Cabell C, Fowler V Jr. Update on infective endocarditis. Curr Probl Cardiol. 2006;31:274–352.PubMedCrossRefPubMedCentralGoogle Scholar
  54. 54.
    Steinbach WJ, Perfect JR, Cabell CH, et al. A meta-analysis of medical versus surgical therapy for Candida endocarditis. J Infect. 2005;51(3):230247.CrossRefGoogle Scholar
  55. 55.
    Arnold CJ, Johnson M, Bayer AS, et al. Candida infective endocarditis: an observational cohort study with a focus on therapy. Antimicrob Agents Chemother. 2015;59(4):2365–73.PubMedPubMedCentralCrossRefGoogle Scholar
  56. 56.
    Chirouze C, Alla F, Fowler VG Jr, et al. Impact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: analysis in the International Collaboration of Endocarditis-Prospective Cohort Study. Clin Infect Dis. 2015;60(5):741–9.PubMedCrossRefPubMedCentralGoogle Scholar
  57. 57.
    Sohail MR, Martin KR, Wilson WR, Baddour LM, Harmsen WS, Steckelberg JM. Medical versus surgical management of Staphylococcus aureus prosthetic valve endocarditis. Am J Med. 2006;119(2):147–54.PubMedCrossRefPubMedCentralGoogle Scholar
  58. 58.
    Garcia-Cabrera E, Fernandez-Hidalgo N, Almirante B, et al. Neurological complications of infective endocarditis: risk factors, outcome, and impact of cardiac surgery: a multicenter observational study. Circulation. 2013;127:2272–84.PubMedCrossRefPubMedCentralGoogle Scholar
  59. 59.
    Iung B, Rousseau-Paziaud J, Cormier B, et al. Contemporary results of mitral valve repair for infective endocarditis. J Am Coll Cardiol. 2004;43:386–92.PubMedCrossRefPubMedCentralGoogle Scholar
  60. 60.
    Duval X, Iung B, Klein I, Brochet E, et al. Effect of early cerebral magnetic resonance imaging on clinical decisions in infective endocarditis: a prospective study. Ann Intern Med. 2010;152:497–504, W175.PubMedCrossRefGoogle Scholar
  61. 61.
    Cooper HA, Thompson EC, Laureno R, et al. Subclinical brain embolization in left-sided infective endocarditis: results from the evaluation by MRI of the brains of patients with left-sided intracardiac solid masses (EMBOLISM) pilot study. Circulation. 2009;120:585–91.PubMedCrossRefGoogle Scholar
  62. 62.
    Iung B, Tubiana S, Klein I, et al. Determinants of cerebral lesions in endocarditis on systematic cerebral magnetic resonance imaging: a prospective study. Stroke. 2013;44:3056–62.PubMedCrossRefGoogle Scholar
  63. 63.
    Tubiana S, et al. Dental procedures, antibiotic prophylaxis, and endocarditis among people with prosthetic heart valves: nationwide population based cohort and a case crossover study. BMJ. 2017;358:j3776.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Gilbert Habib
    • 1
    • 2
  • Maria Abellas-Sequeiros
    • 3
  1. 1.Cardiology DepartmentAPHM, La Timone HospitalMarseilleFrance
  2. 2.IRD, APHM, MEPHI, IHU-Méditerranée Infection, Aix Marseille UniversityMarseilleFrance
  3. 3.Cardiology DepartmentHospital Universitario Ramon y CajalMadridSpain

Personalised recommendations